Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tislelizumab for oesophageal cancer – second line	Tislelizumab (BGB-A317; BGBA-317)	Oesophageal cancer	Head and Neck Cancer	2021	View \| Download
Tislelizumab for advanced non-small cell lung cancer after platinum based chemotherapy	Tislelizumab (BGB-A317; BGBA-317)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2021	View \| Download
Tisagenlecleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma – second line	Tisagenlecleucel-T (Kymriah; CTL019)	B-cell non-Hodgkin lymphoma	Haematological Cancer and Lymphomas	2021	View \| Download
Tisagenlecleucel for relapsed or refractory follicular lymphoma	Tisagenlecleucel-T (Kymriah; CTL019)	Follicular lymphoma	Haematological Cancer and Lymphomas	2021	View \| Download
Tirzepatide for treating type 2 diabetes mellitus	Tirzepatide (LY3298176)	Type 2 diabetes	Endocrine Nutritional and Metabolic Disorders	2021	View \| Download
Tirzepatide for treating obese or overweight adults	Tirzepatide (LY3298176)	Obesity	Cardiovascular System , Ear Nose and Throat (ENT)	2022	View \| Download
Tiratricol for treating monocarboxylate transporter 8 deficiency (Allan-Herndon-Dudley syndrome)	Tiratricol	Monocarboxylate transporter 8 deficiency (Allan-Herndon-Dudley syndrome)	Genetic Disorders , Neurology	2022	View \| Download
Tiragolumab with atezolizumab for treating stage III non-small cell lung cancer after platinum-based chemoradiotherapy	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Tiragolumab with atezolizumab for previously untreated non-small cell lung cancer	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Tiragolumab with atezolizumab for oesophageal squamous cell cancer	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Oesophageal squamous cell carcinoma	Head and Neck Cancer	2023	View \| Download